Oncology & Cancer

PSA failure predicts risk of death only in healthy men

A new study by investigators at Brigham and Women's Hospital (BWH) has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated ...

Oncology & Cancer

MRI scans improve prostate cancer diagnosis in screening trial

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 participants found to have ...

Genetics

Scientists find new gene markers for cancer risk

A huge international effort involving more than 100 institutions and genetic tests on 200,000 people has uncovered dozens of signposts in DNA that can help reveal further a person's risk for breast, ovarian or prostate cancer, ...

Oncology & Cancer

Myths about PSA tests and prostate cancer screening

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate cancer screening, says ...

Oncology & Cancer

Drop in testosterone tied to prostate cancer recurrence

Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. ...

Oncology & Cancer

Early PSA testing could help predict prostate cancer among black men

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It's more common—and more than twice as deadly—among black men compared to their white counterparts. ...

page 13 from 33